|
Clinical impact of BRCA1 and BRCA2 mRNA expression in ovarian cancer. |
|
|
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - Amgen |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - Vertex |
|
|
Research Funding - AstraZeneca (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
No Relationships to Disclose |